Therapy Areas: Hereditary Disorders
12 April 2018 - Enterprise Therapeutics has closed an oversubscribed GBP29m (USD41m) Series B round co-led by Versant Ventures and Novartis Venture Fund, the biopharmaceutical company disclosed on Thu...
6 April 2018 - The United States Food and Drug Administration (FDA) has granted fast track designation to United States-based Proteostasis Therapeutics for its triple combination program to treat cyst...
23 March 2018 - - Cambridge, Massachusetts-based clinical stage biopharmaceutical company Proteostasis Therapeutics, Inc. (NASDAQ: PTI) intends to offer and sell, subject to market and other condition...
21 March 2018 - Healthcare company Johnson & Johnson (NYSE:JNJ) stated on Tuesday that Dominic J. Caruso plans to step down as its executive vice president and chief financial officer in September...
21 March 2018 - Proteostasis Therapeutics Inc (Nasdaq:PTI) said on Tuesday that it has decided not to proceed with its planned public offering of 9,000,000 shares of its common stock in an underwritte...
16 March 2018 - US Food and Drug Administration (USFDA) has granted orphan drug designation to United States-based Proteostasis Therapeutics for its PTI-428, a cystic fibrosis transmembrane conductanc...